Volume: January 2023, Issue 1

Jan 31, 2023 | Hot Topics

AARS News

  • AARS Call for Grant Applications
  • 16th Annual AARS Networking Reception

New Medical Research

  • Selective photothermolysis with a novel 1726 nm laser beam: A safe and effective solution for acne vulgaris.
  • Red light-mediated photoredox catalysis triggers nitric oxide release for treatment of cutibacterium acne induced intervertebral disc degeneration.
  • A combined subcision approach with either fractional CO2 laser (10,600 nm) or cross-linked hyaluronic acid versus subcision alone in atrophic post-acne scar treatment.
  • A single center, prospective, randomized, blinded study to evaluate the efficacy and safety of a topical tripeptide/hexapeptide anhydrous gel when used pre- and post- hybrid fractional laser for the treatment of acne scars.
  • Efficacy and tolerability of hydrafacial clarifying treatment series in the treatment of active acne vulgaris.
  • Fluid platelet-rich fibrin (PRF) versus platelet-rich plasma (PRP) in the treatment of atrophic acne scars: A comparative study.
  • The prevalence, associated factors, and clinical characterization of malassezia folliculitis in patients clinically diagnosed with acne vulgaris.
  • Skin dysbiosis and Cutibacterium acnes biofilm in inflammatory acne lesions of adolescents.
  • Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa.
  • Patterns of surgical recurrence in patients with hidradenitis suppurativa.
  • Bridging the gap: Optimizing skin care in acne treatment.
  • Optimizing skin care in acne treatment – Evaluation of a designated cleanser and moisturizer regimen with improvement in clinical outcomes.
  • “Vehicles matter” in the treatment of truncal acne.
  • Antimicrobial activity of smilax china l. root extracts against the acne-causing bacterium, cutibacterium acnes, and its active compounds.
  • Acne scars: An update on management.

Clinical Reviews

  • Energy-based devices in the treatment of acne scars in skin of color.
  • Antibiotics and antimicrobial resistance in acne: Epidemiological trends and clinical practice considerations.
  • Truncal acne and scarring: A comprehensive review of current medical and cosmetic approaches to treatment and patient management.
  • Acne vulgaris-novel treatment options and factors affecting therapy adherence: A narrative review.
  • Adolescent acne vulgaris: Current and emerging treatments.
  • Chemical peels for atrophic acne scarring: Evolution of peel types and methods.
  • Current medical and surgical treatment of hidradenitis suppurativa-a comprehensive review.
  • The role of hormones in hidradenitis suppurativa: A systematic review.

Related Posts

Volume: July 2024, Issue 1

Volume: July 2024, Issue 1

AARS News AARS July Membership Discount Available to HCPs Amid Paucity of Innovation, New Acne Treatment Guidelines Overlook Critical Issues: Editorial AARS Spotlights #AcneFacts During National Acne Awareness Month AARS Goes One-on-One with Dermatologist Sandra Lee,...

Volume: June 2024, Issue 1

Volume: June 2024, Issue 1

AARS News   Highlights from the 11th Annual AARS Annual Scientific Symposium New Medical Research Isotretinoin for acne in transgender and gender-diverse individuals receiving masculinizing hormone therapy. Efficacy and safety of bimekizumab in patients with...

Volume: May 2024, Issue 1

Volume: May 2024, Issue 1

AARS News   AARS Call for Grant Applications New Medical Research Triple combination clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% for acne: Efficacy and safety from a pooled phase 3 analysis. The role of vitamins and nutrients in rosacea....

Volume: July 2024, Issue 1

Volume: April 2024, Issue 1

AARS News   Register now for the 11th Annual AARS Scientific Symposium AARS Call for Grant Applications Response Statement from the American Acne & Rosacea Society to the Valisure Citizen Petition on Benzene in Benzoyl Peroxide Drug Products New Medical...